Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma.

Autor: Aydin MM; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey., Bayin NS; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey., Acun T; Department of Molecular Biology and Genetics, Faculty of Sciences and Arts, Bülent Ecevit University, Zonguldak, Turkey., Yakicier MC; Department of Molecular Biology and Genetics, Acıbadem University, İstanbul, Turkey., Akçali KC; Department of Biophysics, Ankara University, Faculty of Medicine, Ankara, Turkey.
Jazyk: angličtina
Zdroj: Turkish journal of medical sciences [Turk J Med Sci] 2016 Feb 17; Vol. 46 (2), pp. 572-81. Date of Electronic Publication: 2016 Feb 17.
DOI: 10.3906/sag-1501-173
Abstrakt: Background/aim: Previously we showed that Fms-like tyrosine kinase (FLT3) changes its cellular localization upon partial hepatectomy, suggesting a role in liver regeneration. FLT3 was also shown to play an important function in cellular proliferation and activation of PI3K and Ras. Thus, we aimed to investigate the role of FLT3 in hepatocellular tumorigenesis utilizing in vitro and in vivo models.
Materials and Methods: We used Snu398 cells that express FLT3. We investigated these cells' in vitro proliferation and invasion abilities by treatment with the FLT3 inhibitor K-252a or by knocking-down with FLT3 shRNA,. Furthermore, the effect of blocking FLT3 activity and expression during in vivo tumorigenesis was assessed with xenograft models.
Results: After K-252a treatment or stable knock-down, these cells' proliferation and migration abilities were highly diminished in vitro. In addition, significant diminution in tumorigenicity of Snu398 cells was also obtained in vivo. When FLT3 knocked-down Snu398 cells were injected into nude mice, we did not detect αSMA expression in these tumors, suggesting a role for FLT3 in in vivo invasiveness.
Conclusion: Our data provided evidence that FLT3 has a crucial role both in hepatocarcinogenesis and its invasiveness. Therefore, targeting FLT3 and/or its activity may be a promising tool for combating hepatocellular carcinomas.
Databáze: MEDLINE
Externí odkaz: